Sporotrichoid topographic distribution and Mycobacterium marinum grown on a subdermal contraceptive implant;Dissémination lymphangitique et greffe sur implant contraceptif de Mycobacterium marinum

Revue de Medecine Interne

Volumn 32, Issue 4, 2011, Pages

  Savini, H ^a   Morel, F ^a   Vedy, S ^a   De Biasi, C ^a   Lightburn, E ^a   Garnotel, E ^a   Morand, J J ^a  

^a LAVERAN MILITARY TEACHING HOSPITAL   (France)

Author keywords

Contraceptive implant; Mycobacterium marinum; Sporotrichoid distribution

Indexed keywords

ADULT; ARTICLE; BACTERIAL GROWTH; CASE REPORT; FEMALE; FEMALE CONTRACEPTIVE DEVICE; HUMAN; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIOSIS; MYCOBACTERIUM MARINUM; MYCOBACTERIUM MARINUM INFECTION; RASH; SKIN BIOPSY; SUBDERMAL CONTRACEPTIVE IMPLANT;

ADULT; ANTI-BACTERIAL AGENTS; ARM; CONTRACEPTIVE DEVICES, FEMALE; DEBRIDEMENT; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; FEMALE; FINGERS; HUMANS; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM MARINUM; SKIN DISEASES, BACTERIAL; SPOROTRICHOSIS; TREATMENT OUTCOME;

EID: 79953330805     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2009.10.443     Document Type: Article

References (13)

1. Aubry A., Chosidow O., Caumes E., Robert J., Cambau E. Sixty-three cases of Mycobacterium marinum infection. Clinical features, treatment and antibiotic susceptibility of causative isolates. Arch Intern Med 2002, 162:1746-1752.
2. Morand JJ, Maslin J, Darie H. Manifestations cutanéo-muqueuses des mycobactéries environnementales (dont Mycobacterium ulcerans). Encycl Médico-Chir, Dermatol, Paris, 2005, 98 365 A 10, 16p.
3. Tchornobay A.M., Claudy A.L., Perrot J.L., Lévigne V., Denis M. Fatal disseminated Mycobacterium marinum infection. Int J Dermatol 1992, 31:286-287.
4. Zukervar P., Canillot S., Gayrard L., Perrot H. Infection sporotrichoïde à Mycobacterium marinum chez un sujet porteur de virus de l'immunodéficience humaine (VIH). Ann Dermatol Venereol 1991, 118:111-113.
5. Travis W.D., Travis L.B., Roberts G.D., et al. The histopathologic spectrum in Mycobacterium marinum infection. Arch Pathol Lab Med 1985, 109:1109-1113.
6. Posterato B., Sanguinetti M., Gargovich A., Ardito F., Zampetti A., Masucci L., et al. Polymerase chain reaction-reverse cross blot hybridization assay in the diagnostic of sporotrichoid Mycobacterium marinum infection. Br J Dermatol 1998, 139:872-876.
7. Aubry A., Jarlier V., Escolano S., Truffot-Pernot C., Cambau E. Antibiotic susceptibility pattern of Mycobacterium marinum. Antimicrob Agents Chemother 2000, 44:3133-3136.
8. Ang P., Rattana-Apiromyakij N., Goh C.L. Retrospective study of Mycobacterium marinum skin infections. Int J Dermatol 2000, 39:343-347.
9. Klavon S.L., Grubb G.S. Insertion site complications during the first year of Norplant use. Contraception 1990, 41:27-37.
10. Zuercher D., Malet T. Mycobacterium abscessus infection in a case of recurrent orbital implant exposure. Orbit 2007, 26:337-339.
11. Cheung I., Wilson A. Mycobacterium fortuitum infection following total knee arthroplasty: a case report and literature review. Knee 2008, 15:61-63.
12. Macadam S.A., Mehling B.M., Fanning A., Dufton J.A., Kowalewska-Grochowska K.T., Lennox P., et al. Nontuberculous mycobacterial breast implant infections. Plast Reconstr Surg 2007, 119:337-344.
13. Alfa M.J., Sisler J.J., Harding G.K. Mycobacterium abscessus infection of a Norplant contraceptive implant site. CMAJ 1995, 153:1293-1296.